# The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

> **NCT06304233** · — · ACTIVE_NOT_RECRUITING · sponsor: **Norwegian University of Science and Technology** · enrollment: 120 (estimated)

## Conditions studied

- Heart Diseases
- Heart; Functional Disturbance
- Schizophrenia

## Interventions

- **DIAGNOSTIC_TEST:** Echocardiography
- **DIAGNOSTIC_TEST:** Cardiac Magnetic Resonance Imaging
- **DIAGNOSTIC_TEST:** Electrocardiography
- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT06304233
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-13
- **Primary completion:** 2026-12
- **Final completion:** 2038-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304233, "The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06304233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*